A recent legal case may shape future liability risk for manufacturers of AI-enabled medical devices, including those using imaging AI.
Key Details
- 1Dickson v. Dexcom Inc. is the first case to hold that federal law can preempt state personal injury lawsuits for certain FDA-authorized devices.
- 2The case involves Class II devices cleared via the FDA’s De Novo pathway, frequently used by AI/ML-enabled device manufacturers.
- 3Manufacturers using the De Novo pathway for AI/ML devices do so over three times more than other device manufacturers.
- 4The authors suggest this case could impact future court handling of injury claims involving AI/ML medical devices.
Why It Matters
Legal precedents on product liability directly affect how AI imaging tools are developed, cleared, marketed, and insured. Understanding potential liability exposure is critical for radiology AI startups, manufacturers, and investors.
Source
EurekAlert
Related News
•EurekAlert
Pediatricians Receive AAP Guidance for Safe Use of Generative AI
The American Academy of Pediatrics has issued recommendations to ensure the safe, equitable, and effective use of generative artificial intelligence in pediatric clinical care.
•EurekAlert
Legal Gaps in Explaining AI Decisions to Patients in Imaging
A JMIR article examines the disconnect between AI legal requirements and actual patient comprehension in medical imaging and diagnostics.
•EurekAlert
Expert Consensus Sets Standardized Evaluation for Clinical Large Language Models
An expert consensus provides a robust, evidence-based framework for retrospective evaluation of large language models in healthcare.